Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus

计划入组 14 人 · 首次发布于 2020 年 4 月 21 日

Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma

计划入组 6 人 · 首次发布于 2024 年 8 月 20 日

Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases

计划入组 14 人 · 首次发布于 2022 年 6 月 28 日

Kamari Pharma Secures $23 Million Series A to Advance First-in-Class TRPV3 Inhibitor for Rare Genetic Skin Diseases

Quoin Pharmaceuticals Expands Netherton Syndrome Clinical Trials to the UK

Quoin Pharmaceuticals Achieves High-Concentration Topical Rapamycin Formulations for Rare Vascular Malformations